Skip to main content
. 2023 Aug 29;95(1):79–91. doi: 10.3233/JAD-230350

Table 3.

Incidence of dementia (per 1,000 person-years) of FOXO3 rs2802292 genotypes stratified by late-life hypertension status

A Normotensive Hypertensive (HTN2)
TT TG/GG p 1 TT TG/GG p 1
Total n values 667 570 762 689
All-cause dementia – n 184 153 198 190
age-adjusted incidence 34.4 32.3 0.60 33.8 33.1 0.24
Alzheimer’s disease – n 127 119 144 123
age-adjusted incidence 23. 5 25.1 0.58 24.3 21.3 0.036
Vascular dementia – n 22 12 38 32
age-adjusted incidence 4.27 2.68 0.16 6.64 5.61 0.40
B Normotensive Hypertensive (HTN1)
TT TG/GG p 1 TT TG/GG p 1
Total n value 361 313 1068 946
All-cause dementia – n 96 82 286 261
Age-adjusted incidence 34.5 31.6 0.90 34.2 32.8 0.14
Alzheimer’s disease – n 68 65 203 177
age-adjusted incidence 23.5 25.0 0.40 24.2 22.2 0.071
Vascular dementia – n 10 7 50 37
age-adjusted incidence 4.36 2.93 0.65 6.06 4.72 0.16

1p value for test of incidence rates between FOXO3 genotypes (TT versus TG/GG), estimated using Cox proportional hazard models adjusting for age within each hypertension status. HTN1, SBP/DBP ≥140/90 mmHg or the self-reported use of anti-hypertensive medications; HTN2, SBP/DBP ≥160/95 mmHg or the self-reported use of anti-hypertensive medications.